“Can a purpose-built GenAI platform — trained on clinical and financial data at the health-system level — meaningfully reduce administrative costs and improve revenue integrity across the entire healthcare revenue cycle?”
Founded in 2019, AKASA began as an AI automation company for healthcare revenue cycle management (RCM), initially applying machine learning to tasks like claim status and prior authorization. As generative AI matured, AKASA pivoted to building custom large language models (LLMs) trained on each health system's clinical data, repositioning itself as the leading GenAI platform for the mid-revenue cycle — spanning coding, CDI, and clinical denials. The Cleveland Clinic partnership in 2025 cemented AKASA's position as a serious enterprise GenAI player in healthcare finance, with no embedded finance products of its own.